You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CPD

Difficult Scenarios in CSCC: Can You Manage These Patient Simulations?

  • Authors: Axel Hauschild, MD, PhD; Nikhil Khushalani, MD
  • CPD Released: 6/15/2022
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 6/15/2023, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US oncologists, dermatologists, and pathologists.

The goal of this activity is that learners will be better able to assess, adhere to guidelines, and manage patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC).

Upon completion of this activity, participants will:

  • Have increased performance associated with
    • Identifying patients with CSCC who are candidates for systemic therapy
    • Prescribing the most appropriate therapy for CSCC patients
    • Appropriately monitoring CSCC patients for adverse events


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Axel Hauschild, MD, PhD

    Professor of Dermatology
    Clinic for Dermatology, Venerology and Allergology
    University Hospital Schleswig-Holstein
    Kiel, Germany

    Disclosures

    Axel Hauschild, MD, PhD, has the following financial relationships:
    Consultant or advisor for: Amgen, Bristol-Myers Squibb, MS, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
    Speaker or member of speakers bureau for: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
    Research funding from: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi
    Contracted researcher for: Amgen, Bristol-Myers Squibb, Immunocore, MerckSerono, Merck Sharpe & Dohme, Neracare, Novartis, Philogen, Pierre Fabre, Provectus, Regeneron, Roche, Sanofi

  • Nikhil Khushalani, MD

    Vice Chair
    Department of Cutaneous Oncology
    Moffitt Cancer Center
    Tampa, FL, United States

    Disclosures

    Nikhil Khushalani, MD, has the following financial relationships:
    Consultant or advisor for: Bristol-Myers Squibb Company; Castle; Genzyme; Instill; Iovance; Jounce; Merck; NEKTAR; Novartis; Regeneron
    Research funding from: Amgen; Bristol-Myers Squibb Company; Celgene; GlaxoSmithKline; HUYA; Merck; Novartis; Regeneron; Replimmune
    Owns stock (publicly traded) in: Bellicum
    Other: DSMB for AstraZeneca; Incyte; Steering Committee Member for NEKTAR; Pfizer; Regeneron

Editors

  • Mihai Surducan, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Mihai Surducan, PhD, has no relevant financial relationships.

  • Kathleen Krafton

    Writer, Chichester Associates, Allendale, New Jersey

    Disclosures

    Kathleen Krafton has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.0 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Difficult Scenarios in CSCC: Can You Manage These Patient Simulations?

Authors: Axel Hauschild, MD, PhD; Nikhil Khushalani, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 6/15/2022

Valid for credit through: 6/15/2023, 11:59 PM EST

processing....

Transcrição em português

Download the pdf.

 

« Return to: Difficult Scenarios in CSCC: Can You Manage These Patient Simulations?
  • Print